ResMed Inc. (RMD)

146.34
3.30 2.21
NYSE : Health Technology
Prev Close 149.64
Open 148.98
Day Low/High 145.75 / 148.98
52 Wk Low/High 90.64 / 151.46
Volume 690.57K
Avg Volume 509.30K
Exchange NYSE
Shares Outstanding 143.79M
Market Cap 21.48B
EPS 2.80
P/E Ratio 51.51
Div & Yield 1.56 (1.02%)

Latest News

ResMed Announces Participation In The Credit Suisse 28th Annual Healthcare Conference

ResMed Announces Participation In The Credit Suisse 28th Annual Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28 th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.

S&P Ends Close to Record on Intel Earnings Win, U.S.-China Trade News

S&P Ends Close to Record on Intel Earnings Win, U.S.-China Trade News

Stocks finished higher Friday, as investors focus on Intel's earnings beat and news that the U.S. and China are close to finalizing parts of a phase one deal.

ResMed Inc. Announces Results For The First Quarter Of Fiscal Year 2020

ResMed Inc. Announces Results For The First Quarter Of Fiscal Year 2020

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended September 30, 2019.

Man Sleeping With AirFit N30 (Photo: Business Wire)

Man Sleeping With AirFit N30 (Photo: Business Wire)

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world's first tube-down nasal cradle CPAP mask with a front-facing tube - a brand-new option for sleep apnea treatment.

New Research Reveals Updated Patient Preferences On Digital Health Technology

New Research Reveals Updated Patient Preferences On Digital Health Technology

ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology.

ResMed To Report First Quarter Fiscal 2020 Earnings On October 24, 2019

ResMed To Report First Quarter Fiscal 2020 Earnings On October 24, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2020 on Thursday, October 24, 2019, after the New York Stock Exchange closes.

ResMed To Celebrate 30th Anniversary And 20 Years Listed On The New York Stock Exchange By Ringing The Opening Bell® On September 30, 2019

ResMed To Celebrate 30th Anniversary And 20 Years Listed On The New York Stock Exchange By Ringing The Opening Bell® On September 30, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.

ResMed Announces Participation In The 17th Annual Morgan Stanley Global Healthcare Conference

ResMed Announces Participation In The 17th Annual Morgan Stanley Global Healthcare Conference

ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17 th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019,...

ResMed Inc. Announces Results For The Fourth Quarter Of Fiscal Year 2019

ResMed Inc. Announces Results For The Fourth Quarter Of Fiscal Year 2019

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019.

ResMed Inc. Completes $500M Private Placement Debt Offering

ResMed Inc. Completes $500M Private Placement Debt Offering

ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.

The Lancet Publishes: More Than 936 Million Have Obstructive Sleep Apnea Worldwide

The Lancet Publishes: More Than 936 Million Have Obstructive Sleep Apnea Worldwide

More than 936 million people have obstructive sleep apnea - the disease's first prevalence update in more than a decade - according to The Lancet Respiratory Medicine, the world's leading journal in its field.

ResMed To Report Fourth Quarter Fiscal 2019 Earnings On July 25, 2019

ResMed To Report Fourth Quarter Fiscal 2019 Earnings On July 25, 2019

ResMed (NYSE: RMD) (ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2019 on Thursday, July 25, 2019, after the New York Stock Exchange closes.

ResMed Could Rally Another 25% From Here

ResMed Could Rally Another 25% From Here

Here's how to play the stock now.

Market Outlook: Cramer's 'Mad Money' Recap (Friday 6/14/19)

Market Outlook: Cramer's 'Mad Money' Recap (Friday 6/14/19)

Jim Cramer's got the low-down on IPOs, the Fed, trade and more. Here's your game plan for next week's action.

Nucor, Wells Fargo, ResMed: 'Mad Money' Lightning Round

Nucor, Wells Fargo, ResMed: 'Mad Money' Lightning Round

Jim Cramer weighs in on Nucor, Wells Fargo, ResMed, Gulfport Energy, JD.com, Alibaba.

New Analysis Shows Sleep Apnea More Common In Americas Than Previously Thought

New Analysis Shows Sleep Apnea More Common In Americas Than Previously Thought

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research...

ResMed Announces Participation In The 40th Annual Goldman Sachs Global Healthcare Conference

ResMed Announces Participation In The 40th Annual Goldman Sachs Global Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a fireside chat discussion at the 40 th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019, beginning at...

ResMed Announces Participation In The 39th Annual William Blair Growth Stock Conference

ResMed Announces Participation In The 39th Annual William Blair Growth Stock Conference

ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39 th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.

ResMed Study Finds CPAP Adherence Improved By Remote Monitoring, Self-Monitoring Across 3 Countries

ResMed Study Finds CPAP Adherence Improved By Remote Monitoring, Self-Monitoring Across 3 Countries

Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society's 2019 ATS International Conference.

Age, Gender, Disease Severity Impact Adherence To Long-Term PAP Therapy More Than Previously Thought

Age, Gender, Disease Severity Impact Adherence To Long-Term PAP Therapy More Than Previously Thought

ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thoracic Society's ATS 2019 International Conference.

ResMed Elects Jan De Witte To Its Board Of Directors

ResMed Elects Jan De Witte To Its Board Of Directors

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital SaaS solutions, today announced it has elected experienced business executive Jan De Witte to its board of directors.

Brightree Announces Access To CommonWell Health Alliance Network For Home Health And Hospice Customers

Brightree Announces Access To CommonWell Health Alliance Network For Home Health And Hospice Customers

Brightree ® today announced plans for its Home Health and Hospice customers to access more than 50,000 provider locations and health systems nationwide via the CommonWell Health Alliance, a nonprofit national trade association of health IT companies, and...

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2019

ResMed Inc. Announces Results For The Third Quarter Of Fiscal Year 2019

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended March 31, 2019.

ResMed To Report Third Quarter Fiscal 2019 Earnings On May 2, 2019

ResMed To Report Third Quarter Fiscal 2019 Earnings On May 2, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.

AirFit P30i Nasal Pillows Tube-up CPAP Mask, Side View (Photo: Business Wire)

AirFit P30i Nasal Pillows Tube-up CPAP Mask, Side View (Photo: Business Wire)

ResMed (NYSE: RMD, ASX: RMD) today introduced its second top-of-head-connected CPAP mask for treating sleep apnea, a new nasal pillows option, AirFit P30i.

Brightree ReSupply Solution Expands Beyond Sleep To 3 More Disease Segments

Brightree ReSupply Solution Expands Beyond Sleep To 3 More Disease Segments

Brightree ® today announced that its Brightree ReSupply solution for home medical equipment (HME) providers has expanded to support additional categories outside of sleep therapy, including incontinence, diabetic, and enteral segments.

Brightree Introduces First-of-its-kind Analytics Suite For HMEs

Brightree Introduces First-of-its-kind Analytics Suite For HMEs

Brightree ® today introduced Advanced Analytics, the first analytics platform for HMEs that highlights workflow insights, KPI tracking, and peer benchmarking, without requiring users to aggregate data themselves.

ResMed Launches Next-generation ReSupply Solution

ResMed Launches Next-generation ReSupply Solution

ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed ReSupply solution for all U.

TheStreet Quant Rating: A- (Buy)